AstraZeneca Veteran Hasan Jafri Joins Aridis as Chief Medical Officer

Aridis Pharmaceuticals (NASDAQ: [[ticker:ARDS]]) has appointed Hasan Jafri to serve as its chief medical officer. He succeeds Paul Mendelman, the company’s interim CMO since last October. San Jose, CA-based Aridis said Mendelman will become senior medical advisor to the company. Jafri is joining Aridis from AstraZeneca (NYSE: [[ticker:AZN]]), where he was director of clinical research and development for infectious disease and vaccines. Aridis is developing drugs to treat life-threatening bacterial infections.

Author: Frank Vinluan

Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times. View all posts by Frank Vinluan